ARTICLE | Company News
Igen other research news
February 26, 2001 8:00 AM UTC
IGEN signed a letter of intent to enter a CRADA with the National Cancer Institute for the development of Origen-based assays that detect ubiquitin, a cell signaling molecule that targets proteins for...